“…As sample size limitations precluded an examination of the possible interaction between the treatment group and the underlying syndrome and/or neuromuscular condition, we were unable to statistically determine whether the underlying etiology impacts treatment outcomes. However, because vertical talus, like many musculoskeletal disorders, is genetically and etiologically heterogeneous, the underlying cause is likely to affect outcomes, as studies (including ours) suggest 10,19,20,22,23,25 .…”